| Income Statement |
| Total Revenue | 4.05B |
|
| Revenues (USD) | 4.05B |
| Cost of Revenue | 3.61B |
| Gross Profit | 437.20M |
| Operating Expenses | 164.90M |
| Research and Development Expense | 41.20M |
| Selling, General and Administrative Expense | 117.40M |
| Operating Income | 272.30M |
| Interest Expense | 16.00M |
| Income Tax Expense | 44.00M |
| Net Income | 212.30M |
| Net Income Common Stock | 212.30M |
| Net Income Common Stock (USD) | 212.30M |
| Consolidated Income | 212.30M |
| Earnings per Basic Share | 1.85 |
| Earnings per Basic Share (USD) | 1.85 |
| Earnings per Diluted Share | 1.83 |
| Earning Before Interest & Taxes (EBIT) | 272.30M |
| Earning Before Interest & Taxes (USD) | 272.30M |
| Weighted Average Shares | 114.90M |
| Weighted Average Shares Diluted | 115.70M |
| Balance Sheet |
| Cash and Equivalents | 378.00M |
| Cash and Equivalents (USD) | 378.00M |
| Trade and Non-Trade Receivables | 3.17B |
| Current Assets | 6.40B |
| Property, Plant & Equipment Net | 861.10M |
| Total Assets | 8.26B |
| Debt Current | 25.90M |
| Total Debt | 772.40M |
| Current Liabilities | 5.08B |
| Debt Non-Current | 746.50M |
| Total Liabilities | 6.16B |
| Shareholders Equity | 2.10B |
| Shareholders Equity (USD) | 2.10B |
| Assets Non-Current | 1.86B |
| Total Debt (USD) | 772.40M |
| Goodwill and Intangible Assets | 588.60M |
| Inventory | 2.67B |
| Liabilities Non-Current | 1.08B |
| Trade and Non-Trade Payables | 3.09B |
| Tax Assets | 182.30M |
| Tax Liabilities | 214.50M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 39.60M |
| Net Cash Flow from Financing | -355.50M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -217.60M |
| Capital Expenditure | -218.40M |
| Issuance (Purchase) of Equity Shares | -348.10M |
| Issuance (Repayment) of Debt Securities | -7.40M |
| Net Cash Flow from Investing | -218.40M |
| Net Cash Flow from Operations | 356.30M |
| Share Based Compensation | 30.50M |